Literature DB >> 27605511

The CLL-IPI applied in a population-based cohort.

Caspar da Cunha-Bang1, Ilse Christiansen2, Carsten Utoft Niemann1.   

Abstract

Mesh：

Year:  2016        PMID： 27605511     DOI： 10.1182/blood-2016-07-724740

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

Review 1.  On the architecture of translational research designed to control chronic lymphocytic leukemia.

Authors:  Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.

Authors:  Julio Delgado; Ferran Nadeu; Dolors Colomer; Elias Campo
Journal:  Haematologica       Date:  2020-07-02       Impact factor: 9.941

Review 3.  Current Treatment of Chronic Lymphocytic Leukemia.

Authors:  Krzysztof Jamroziak; Bartosz Puła; Jan Walewski
Journal:  Curr Treat Options Oncol       Date:  2017-01

4.  and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.

Authors:  Michael Asger Andersen; Casper Tabassum Eriksen; Christian Brieghel; Jorne Lionel Biccler; Caspar da Cunha-Bang; Marie Helleberg; Carsten Utoft Niemann
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

Review 5.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 6.  Optimizing frontline therapy of CLL based on clinical and biological factors.

Authors:  Kirsten Fischer; Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.

Authors:  Inger Lise Gade; Signe Juul Riddersholm; Ilse Christiansen; Annika Rewes; Mikael Frederiksen; Lisbeth Enggaard; Christian Bjørn Poulsen; Olav Jonas Bergmann; Dorte Balle Gillström; Robert Schou Pedersen; Linda Nielsen; Helle Højmark Eriksen; Christian Torp-Pedersen; Søren Risom Kristensen; Marianne Tang Severinsen
Journal:  Blood Adv       Date:  2018-11-13

8.  Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia.

Authors:  C Owen; A S Gerrie; V Banerji; S Assouline; C Chen; K S Robinson; E Lye; G Fraser
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

9.  The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.

Authors:  Sameer A Parikh; Kari G Rabe; Neil E Kay; Timothy G Call; Wei Ding; Jose F Leis; Saad S Kenderian; Eli Muchtar; Yucai Wang; Amber B Koehler; Susan M Schwager; Connie E Lesnick; Geffen Kleinstern; Daniel Van Dyke; Curtis A Hanson; Esteban Braggio; Susan L Slager; Tait D Shanafelt
Journal:  Blood       Date:  2021-07-15       Impact factor: 25.476

10.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.